NCT05041348View on ClinicalTrials.gov

Metabonomic of Patients With Hepatitis B Cirrhosis Complicated With Sarcopenia.

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

August 17, 2022

Conditions
Sarcopenia
Interventions
DIAGNOSTIC_TEST

CT at the level of the third lumbar vertebra (L3)

Muscle mass loss was defined as an skeletal muscle mass index (SMI) less than 46.96 cm²/m² for males and less than 32.46 cm²/m² for females

Trial Locations (1)

266003

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05041348 - Metabonomic of Patients With Hepatitis B Cirrhosis Complicated With Sarcopenia. | Biotech Hunter | Biotech Hunter